GUT Permeability Assay
The intestinal permeability assay is a pivotal in vitro cell based assay to assess the ability of a substance to permeate across intestinal epithelium. It is commonly employed to estimate the absorption of orally administered drugs, and to predict their bioavailability.
Purpose of the Test
Gut permeation assay evaluates the intestinal absorption and permability of drugs and substances after their oral administration. It is essential for determining the fraction absorbed and predicting in vivo bioavailability. It utilizes an advanced in vitro fluid dynamic gut model to mimic the intestinal barrier, and measure the apparent permeability coefficient (Papp) to classify compounds as highly or poorly permeable.
Regulatory Compliance
The assay is aligned with international guidelines to provide evidence for drug absorption and support regulatory submissions, according to the BCS guidelines established by regulatory bodies like the FDA and EMA.
The MIVO® Advantage: A Superior Predictive Model
MIVO® gut on chip technology offers a superior model for evaluating intestinal permeability by closely mimicking the physiological conditions of the human intestine, compared to static caco2 cell based assay. The dynamic flow platform closely mimics lumen and circulatory flow conditions, providing superior accuracy in evaluating gut permeability.
Our Unique Value Proposition
Gut Absorption Assay
In summary
READOUTS
- Analytical quantification of kinetics of the fraction of moleculesabsorbed
- Measure of apparent permeability coefficient (Papp)
Get a Quote
We are here for you
Whether you’re looking for a quote or want to connect with us, fill out the form below with your details, and we will be in touch shortly.
All fields are required, take your time.